A variety of chemically different prooxidants causes Ca2+ release from mitochondria. This prooxidant-induced Ca2+ release occurs from intact mitochondria via a route which is physiologically relevant and may be regulated by protein monoADP-ribosylation. When the released Ca2+ is excessively 'cycled' by mitochondria (continuously taken up and released) the inner membrane is damaged. This leads to a decreased ability of mitochondria to retain Ca2+, uncoupling of mitochondria, and an impairment of ATP synthesis, which in turn deprives the cell of the energy necessary for the proper functioning of the Ca2+ ATPases of the endoplasmic (sarcoplasmic) reticulum, the nucleus and the plasma membrane. The ensuing rise of the cytosolic Ca2+ level cannot be counterbalanced by the damaged mitochondria which, under normoxic conditions, act as a safety device against an increase of the cytosolic Ca2+ concentration. The impaired ability of mitochondria to retain Ca2+ may lead to cell death. However, there is also evidence emerging that release of Ca2+ from mitochondria may be physiologically important for cell proliferation and differentiation.